Local hyperthermia, radiation, and chemotherapy in preirradiated recurrent lymph node metastases of head and neck cancer

Combining Hyperthermia, Radiation, and Chemotherapy for Head and Neck Cancer

Sample size: 22 publication Evidence: moderate

Author Information

Author(s): T. Feyerabend, B. Jager, M. Marx, E. Richter

Primary Institution: Medical University of Lubeck, Germany

Hypothesis

Can the addition of cisplatin to hyperthermia and radiation improve treatment outcomes in recurrent lymph node metastases of head and neck cancer?

Conclusion

Triple modality therapy in recurrent lymph node metastases of head and neck cancer is an effective palliative treatment with a high response rate, but low complete response rate.

Supporting Evidence

  • A mean total dose of 35 Gy was applied with a mean of 3 sessions of hyperthermia and cisplatin.
  • The overall remission rate was 86%, but the complete response rate was only 14%.
  • Toxicity included one episode of grade 3 skin reaction and one episode of grade 2 leukopenia.

Takeaway

Doctors combined heat treatment, radiation, and a medicine called cisplatin to help patients with cancer in their neck, and many patients got better, but not all of them got completely well.

Methodology

Patients received either conventionally fractionated or hyperfractionated radiation combined with hyperthermia and cisplatin.

Limitations

The study had a small sample size and a low complete response rate.

Participant Demographics

Patients suffering from preirradiated recurrent lymph node metastases of ENT cancer.

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication